MNPR Monopar Therapeutics Inc.
Healthcare$63.12+0.70%ClosedMarket Cap: $422.8M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$115.00
Target (Median)
$115.00
Target Range
$115.00 - $115.00
Upside from current price: 82.2%
Rating Distribution
4 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-30 | Chardan Capital | maintain | Buy | Buy |
| 2026-02-23 | BTIG | maintain | Buy | Buy |
| 2026-01-29 | Chardan Capital | maintain | Buy | Buy |
| 2026-01-14 | BTIG | maintain | Buy | Buy |
| 2025-11-14 | Raymond James | downgrade | Outperform | Strong Buy |
| 2025-11-13 | Chardan Capital | maintain | Buy | Buy |
| 2025-10-06 | Raymond James | maintain | Strong Buy | Strong Buy |
| 2025-10-02 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-09-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-25 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.30 | $400.0K | 10 |
| Fri Dec 31 | $-3.29 | $15.4M | 7 |
| Sun Dec 31 | $-1.41 | $82.9M | 7 |
| Mon Dec 31 | $1.41 | $162.7M | 2 |